Infectious Disease Testing/Diagnostic Market - Forecast(2021 - 2026)
The Infectious Disease Testing Market size is forecast to reach $23.45 billion by 2025, growing at a CAGR of 5.8% during the forecast period 2020-2025. Infectious disease is caused by bacteria, viruses, and others and has a huge impact on the Healthcare systems of the countries. Infectious disease testing is the process of identification of causative organisms for the primary diagnosis of diseases. Infectious diseases testing samples include blood, urine, and other bodily fluids. Growing demand for rapid diagnostic techniques over the current techniques owing to the long turnaround time and supportive government funding along with the growing awareness for early detection using specific Diagnostic tests is the major factor driving the growth of the market. The shift in focus from centralized laboratories to decentralized point-of-care testing services is set to further enhance the overall market demand for the Infectious Disease Testing Market during the forecast period 2020-2025.
Report Coverage
- North America dominated the Infectious Disease Testing Market in 2019 owing to the increasing investments by healthcare providers towards infrastructure, improvement and the need to manage the growing burden of infectious diseases. The Infectious Disease Testing Market scope for different regions will be provided in the final report.
- Increasing epidemics of infectious diseases requires continuous testing and changing regulatory policies to mandate the infectious disease testing for the general population is likely to aid in the market growth of the Infectious Disease Testing Market.
- Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Infectious Disease Testing Market report.
- Unfavourable and inadequate reimbursement scenario is poised to create hurdles for the Infectious Disease Testing Market.
Infectious Disease Testing Market Segment Analysis - By Disease Type
North America dominated the Infectious Disease Testing Market in 2019 with a share of more than 36.12%, followed by Europe owing to the rapid urbanization, increasing investments by healthcare providers towards infrastructure improvement, need to manage the growing burden of infectious diseases, and government efforts to improve the accessibility of diagnostic services to enhance the prevention by developing products or platforms required for the diagnosis of infectious diseases. Further, changing regulatory policies to mandate the infectious disease testing for the general population fueled the growth of the market. Along with these, technology has integrated the existing manual operations and led to the development of a fully automated process. Thus, increasing the growth of the Infectious Disease Testing Market in this region.
However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2020-2025 owing to the growing presence of a highly developed healthcare system, increasing prevalence of infectious diseases, the presence of a large number of leading national clinical laboratories, and easy accessibility to technologically advanced instruments in the region.
"We also publish more than 100 reports every month in “Lifesciences and Healthcare”, Go through the Domain if there are any other areas for which you would like to get a market research study."
Comments
Post a Comment